ArticleClinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico2026
Active recruitment for vaccination of patients with solid-organ cancer through the surgical pathway.
Article in Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTo evaluate the effectiveness of an active recruitment strategy for vaccinating patients with solid-organ cancer through the scheduled surgery unit of a regional hospital.
methodsA descriptive study of patients identified between February 13, 2023, and December 20, 2024, using daily records of scheduled oncologic surgery. The Department of Preventive Medicine and Public Health sent an informational letter, an educational brochure, and an appointment notice to the Vaccination Unit.
resultsA total of 143 patients were identified; 18 were excluded, and 125 were included in the analysis. One hundred twenty (96.0%) attended the first appointment, and 116 (96.7% of attendees) began the vaccination series. Vaccination coverage rates were 96.64% for pneumococcal, 94.96% for shingles, and 78.15% for influenza and COVID-19.
conclusionsEarly outreach integrated into the surgical process was feasible and achieved high vaccination coverage in a particularly vulnerable population.
Indexed as
Identifiers
42426437What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.